NFKB1 and nasopharyngeal carcinoma: While EBNA1 is reported to enhance phosphorylation of STAT1 in one gastric cancer cell line and two nasopharyngeal cancer cell lines, it inhibits anti-tumor TGF-β1 and NF-κB pathways, promoting tumorigenesis (93, 94).